Paroxetine mitigates cardiac remodelling by doxorubicin and increases survival
Doxorubicin (DOX) is an effective anticancer drug. However, its use is hampered by the development of very mortal cardiomyopathy. Here, we investigate whether the co-administration of the antidepressant paroxetine (P), known to exert beneficial cardiovascular effects, would provide effective cardiop...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Elsevier
2022
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/ae3305f41fc244d78b45f5e1dcb8c74c |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|